Alternatives to Charles River Laboratories International, Inc.

A global leader in clinical pharmacology and bioanalytical sciences.

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

Israel's leading bio-foundry for synthetic biology innovation, spanning ideation to proof-of-concept.

Leveraging AI and advanced analytics to drive innovation in healthcare and life sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing novel male contraceptives.

Global contract research, development, and manufacturing organization for pharmaceutical and biopharmaceutical industries.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

AI-powered research assistant for scientific literature review and data extraction.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A clinical-stage biopharmaceutical company developing novel immunotherapies.